|
1
|
Yang JD, Hainaut P, Gores GJ, Amadou A,
Plymoth A and Roberts LR: A global view of hepatocellular
carcinoma: Trends, risk, prevention and management. Nat Rev
Gastroenterol Hepatol. 16:589–604. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang CH, Wey KC, Mo LR, Chang KK, Lin RC
and Kuo JJ: Current trends and recent advances in diagnosis,
therapy, and prevention of hepatocellular carcinoma. Asian Pac J
Cancer Prev. 16:3595–3604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sherman M: Hepatocellular carcinoma:
Epidemiology, surveillance, and diagnosis. Semin Liver Dis.
30:3–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iwama H, Masaki T and Kuriyama S:
Abundance of microRNA target motifs in the 3′-UTRs of 20527 human
genes. FEBS Lett. 581:1805–1810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M,
et al: Combinatorial microRNA target predictions. Nat Genet.
37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: Metazoan MicroRNAs. Cell.
173:20–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tomasello L, Cluts L and Croce CM:
Experimental validation of microRNA targets: Mutagenesis of binding
regions. Methods Mol Biol. 1970:331–339. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Varnholt H, Drebber U, Schulze F,
Wedemeyer I, Schirmacher P, Dienes HP and Odenthal M: MicroRNA gene
expression profile of hepatitis C virus-associated hepatocellular
carcinoma. Hepatology. 47:1223–1232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Visone R and Croce CM: miRNAs and cancer.
Am J Pathol. 174:1131–1138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morishita A and Masaki T: miRNA in
hepatocellular carcinoma. Hepatol Res. 45:128–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calin GA, Liu CG, Sevignani C, Ferracin M,
Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, et al:
MicroRNA profiling reveals distinct signatures in B cell chronic
lymphocytic leukemias. Proc Natl Acad Sci USA. 101:11755–11760.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sevignani C, Calin GA, Siracusa LD and
Croce CM: Mammalian microRNAs: A small world for fine-tuning gene
expression. Mamm Genome. 17:189–202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Metzler M, Wilda M, Busch K, Viehmann S
and Borkhardt A: High expression of precursor microRNA-155/BIC RNA
in children with Burkitt lymphoma. Genes Chromosomes Cancer.
39:167–169. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Michael MZ, O'Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
18
|
Tokarz P and Blasiak J: The role of
microRNA in metastatic colorectal cancer and its significance in
cancer prognosis and treatment. Acta Biochim Pol. 59:467–474. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Del Vescovo V and Denti MA: microRNA and
lung cancer. Adv Exp Med Biol. 889:153–177. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang X, Liang L, Zhang XF, Jia HL, Qin Y,
Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, et al: MicroRNA-26a
suppresses tumor growth and metastasis of human hepatocellular
carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology.
58:158–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu Y, Lu Y, Zhang Q, Liu JJ, Li TJ, Yang
JR, Zeng C and Zhuang SM: MicroRNA-26a/b and their host genes
cooperate to inhibit the G1/S transition by activating the pRb
protein. Nucleic Acids Res. 40:4615–4625. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow
P, Chung AYF, Jooi LLP and Lee CG: Lethal-7 is down-regulated by
the hepatitis B virus × protein and targets signal transducer and
activator of transcription 3. J Hepatol. 53:57–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Z, Lin S, Li JJ, Xu Z, Yao H, Zhu X,
Xie D, Shen Z, Sze J, Li K, et al: MYC protein inhibits
transcription of the microRNA cluster MC-let-7a-1~let-7d via
noncanonical E-box. J Biol Chem. 286:39703–39714. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsang WP and Kwok TT: Let-7a microRNA
suppresses therapeutics-induced cancer cell death by targeting
caspase-3. Apoptosis. 13:1215–1222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Di Fazio P, Montalbano R, Neureiter D,
Alinger B, Schmidt A, Merkel AL, Quint K and Ocker M:
Downregulation of HMGA2 by the pan-deacetylase inhibitor
panobinostat is dependent on hsa-let-7b expression in liver cancer
cell lines. Exp Cell Res. 318:1832–1843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu XM, Wu LJ, Xu J, Yang R and Wu FS:
Let-7c microRNA expression and clinical significance in
hepatocellular carcinoma. J Int Med Res. 39:2323–2329. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lan FF, Wang H, Chen YC, Chan CY, Ng SS,
Li K, Xie D, He ML, Lin MC and Kung HF: Hsa-let-7g inhibits
proliferation of hepatocellular carcinoma cells by downregulation
of c-Myc and upregulation of p16(INK4A). Int J Cancer. 128:319–331.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Traister A, Shi W and Filmus J: Mammalian
Notum induces the release of glypicans and other GPI-anchored
proteins from the cell surface. Biochem J. 410:503–511. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li N, Gao W, Zhang YF and Ho M: Glypicans
as Cancer Therapeutic Targets. Trends Cancer. 4:741–754. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Capurro MI, Xu P, Shi W, Li F, Jia A and
Filmus J: Glypican-3 inhibits Hedgehog signaling during development
by competing with patched for Hedgehog binding. Dev Cell.
14:700–711. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shirakawa H, Suzuki H, Shimomura M, Kojima
M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N,
Kinoshita T, et al: Glypican-3 expression is correlated with poor
prognosis in hepatocellular carcinoma. Cancer Sci. 100:1403–1407.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang J, Zhang M, Ma H, Song X, He L, Ye X
and Li X: Overexpression of glypican-3 is a predictor of poor
prognosis in hepatocellular carcinoma: An updated meta-analysis.
Medicine (Baltimore). 97:e111302018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fujihara S, Kato K, Morishita A, Iwama H,
Nishioka T, Chiyo T, Nishiyama N, Miyoshi H, Kobayashi M, Kobara H,
et al: Antidiabetic drug metformin inhibits esophageal
adenocarcinoma cell proliferation in vitro and in
vivo. Int J Oncol. 46:2172–2180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fujita K, Iwama H, Sakamoto T, Okura R,
Kobayashi K, Takano J, Katsura A, Tatsuta M, Maeda E, Mimura S, et
al: Galectin-9 suppresses the growth of hepatocellular carcinoma
via apoptosis in vitro and in vivo. Int J Oncol.
46:2419–2430. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Towbin H, Staehelin T and Gordon J:
Electrophoretic transfer of proteins from polyacrylamide gels to
nitrocellulose sheets: Procedure and some applications. Proc Natl
Acad Sci USA. 76:4350–4354. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Stat Soc B. 57:289–300. 1995.
|
|
39
|
Chen Y-H, Song Y, Yu YL, Cheng W and Tong
X: miRNA-10a promotes cancer cell proliferation in oral squamous
cell carcinoma by upregulating GLUT1 and promoting glucose
metabolism. Oncol Lett. 17:5441–5446. 2019.PubMed/NCBI
|
|
40
|
Pal R and Greene S: microRNA-10b is
overexpressed and critical for cell survival and proliferation in
medulloblastoma. PLoS One. 10:e01378452015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Werk AN, Bruckmueller H, Haenisch S and
Cascorbi I: Genetic variants may play an important role in
mRNA-miRNA interaction: Evidence for haplotype-dependent
downregulation of ABCC2 (MRP2) by miRNA-379. Pharmacogenet
Genomics. 24:283–291. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nishida T and Kataoka H: Glypican
3-targeted therapy in hepatocellular carcinoma. Cancers (Basel).
11:E13392019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vongchan P and Linhardt RJ:
Characterization of a new monoclonal anti-glypican-3 antibody
specific to the hepatocellular carcinoma cell line, HepG2. World J
Hepatol. 9:368–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Singh AK, Kumar R and Pandey AK:
Hepatocellular Carcinoma: Causes, Mechanism of Progression and
Biomarkers. Curr Chem Genomics Transl Med. 12:9–26. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou F, Shang W, Yu X and Tian J:
Glypican-3: A promising biomarker for hepatocellular carcinoma
diagnosis and treatment. Med Res Rev. 38:741–767. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang L, Yao M, Pan LH, Qian Q and Yao DF:
Glypican-3 is a biomarker and a therapeutic target of
hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int.
14:361–366. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lai JP, Sandhu DS, Yu C, Han T, Moser CD,
Jackson KK, Guerrero RB, Aderca I, Isomoto H, Garrity-Park MM, et
al: Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth
factor signaling, and decreases survival in hepatocellular
carcinoma. Hepatology. 47:1211–1222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Huo W, Zhu XM, Pan XY, Du M, Sun Z and Li
ZM: MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal
transition via downregulating SULF2 expression in non-small-cell
lung cancer. Math Biosci Eng. 16:4607–4621. 2019. View Article : Google Scholar : PubMed/NCBI
|
